Spots Global Cancer Trial Database for Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
Official Title: An Open-Label, Multicenter, Single Arm Phase II Study of Oral GW572016 as Single Agent Therapy in Subjects With Advanced or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin Containing Regimens
Study ID: NCT00051103
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the efficacy of an oral investigational drug for the treatment of metastatic breast cancer tumors that are known to overexpress HER2/neu.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
GSK Investigational Site, Chula Vista, California, United States
GSK Investigational Site, Los Angeles, California, United States
GSK Investigational Site, Poway, California, United States
GSK Investigational Site, Fort Myers, Florida, United States
GSK Investigational Site, Plantation, Florida, United States
GSK Investigational Site, Savannah, Georgia, United States
GSK Investigational Site, Park Ridge, Illinois, United States
GSK Investigational Site, Skokie, Illinois, United States
GSK Investigational Site, Skokie, Illinois, United States
GSK Investigational Site, Bettendorf, Iowa, United States
GSK Investigational Site, Des Moines, Iowa, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Royal Oak, Michigan, United States
GSK Investigational Site, Billings, Montana, United States
GSK Investigational Site, Hooksett, New Hampshire, United States
GSK Investigational Site, Durham, North Carolina, United States
GSK Investigational Site, Greenville, North Carolina, United States
GSK Investigational Site, Hickory, North Carolina, United States
GSK Investigational Site, Fargo, North Dakota, United States
GSK Investigational Site, Oklahoma City, Oklahoma, United States
GSK Investigational Site, Tulsa, Oklahoma, United States
GSK Investigational Site, Pittsburgh, Pennsylvania, United States
GSK Investigational Site, Columbia, South Carolina, United States
GSK Investigational Site, Germantown, Tennessee, United States
GSK Investigational Site, Memphis, Tennessee, United States
GSK Investigational Site, Memphis, Tennessee, United States
GSK Investigational Site, Nashville, Tennessee, United States
GSK Investigational Site, Nashville, Tennessee, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Salem, Virginia, United States
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
